# Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

> **NCT05416151** · NA · COMPLETED · sponsor: **Danone Global Research & Innovation Center** · enrollment: 486 (actual)

## Conditions studied

- Gastro-intestinal Symptoms in Healthy Subjects

## Interventions

- **OTHER:** Freeze-dried biotic
- **OTHER:** Maltodextrin

## Key facts

- **NCT ID:** NCT05416151
- **Lead sponsor:** Danone Global Research & Innovation Center
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-24
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-04-18
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416151, "Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05416151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
